Clinical Trial Update: A Study to Evaluate the Effect of the Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, on Pulmonary Gas Transfer and Respiration in Patients With Congestive Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating TRPV4 blocker GSK2798745 for pulmonary gas transfer and respiration in heart failure; study completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• GSK2798745

Snippet

Sponsor: GlaxoSmithKline | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2018-09-05